Abstract
The dopamine receptor agonist apomorphine has been used successfully to treat on-off swings in Parkinson's disease. Its value as a predictor of dopa responsiveness in idiopathic Parkinson's disease (IPD) was assessed and its potential role in differentiating IPD from the Parkinsonian plus syndromes (PPS) of multisystem atrophy, progressive supranuclear palsy and olivopontocerebellar atrophy was investigated. The response to an injection of apomorphine was observed in 20 patients with IPD and eight with PPS after being off levodopa for 12 hours. Patients were reassessed after taking levodopa for one month. Nineteen of the 20 patients (95%) with IPD showed a positive response to apomorphine and 18 (90%) to oral levodopa. In the PPS group, two patients (25%) responded to the apomorphine injection but not to oral levodopa. Apomorphine produced severe drowsiness in the PPS patients. It is suggested that the test can predict dopa responsiveness in IPD and may be of help in confirming a doubtful diagnosis. It has potential value in differentiating IPD from PPS.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Barker R., Duncan J., Lees A. Subcutaneous apomorphine as a diagnostic test for dopaminergic responsiveness in parkinsonian syndromes. Lancet. 1989 Mar 25;1(8639):675–675. doi: 10.1016/s0140-6736(89)92183-1. [DOI] [PubMed] [Google Scholar]
- Chanson P., Timsit J., Masquet C., Guillausseau P. J., Warnet A., Lubetzki J. Heart failure responding to octreotide in patient with acromegaly. Lancet. 1989 Jun 3;1(8649):1263–1264. doi: 10.1016/s0140-6736(89)92355-6. [DOI] [PubMed] [Google Scholar]
- Chaudhuri K. R., Critchley P., Abbott R. J., Pye I. F., Millac P. A. Subcutaneous apomorphine for on-off oscillations in Parkinson's disease. Lancet. 1988 Nov 26;2(8622):1260–1260. doi: 10.1016/s0140-6736(88)90860-4. [DOI] [PubMed] [Google Scholar]
- Hughes A. J., Lees A. J., Stern G. M. Apomorphine test to predict dopaminergic responsiveness in parkinsonian syndromes. Lancet. 1990 Jul 7;336(8706):32–34. doi: 10.1016/0140-6736(90)91531-e. [DOI] [PubMed] [Google Scholar]
- Rascol O., Senard J. M., Rascol A., Montastruc J. L. Apomorphine test in parkinsonian syndromes. Lancet. 1990 Aug 25;336(8713):518–518. doi: 10.1016/0140-6736(90)92079-w. [DOI] [PubMed] [Google Scholar]
- Stibe C. M., Lees A. J., Kempster P. A., Stern G. M. Subcutaneous apomorphine in parkinsonian on-off oscillations. Lancet. 1988 Feb 20;1(8582):403–406. doi: 10.1016/s0140-6736(88)91193-2. [DOI] [PubMed] [Google Scholar]